<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1266576</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Methods in T cell biology: 2022</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Aguado</surname>
<given-names>Enrique</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/83695"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Call</surname>
<given-names>Matthew E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/464809"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Inflammation Program, Institute of Biomedical Research Cadiz (INIBICA)</institution>, <addr-line>C&#xe1;diz</addr-line>, <country>Spain</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Biomedicine, Biotechnology and Public Health (Immunology), University of C&#xe1;diz</institution>, <addr-line>C&#xe1;diz</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Structural Biology Division, Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Medical Biology, University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Mariolina Salio, Immunocore, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Enrique Aguado, <email xlink:href="mailto:enrique.aguado@uca.es">enrique.aguado@uca.es</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1266576</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Aguado and Call</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Aguado and Call</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/42493" ext-link-type="uri">Editorial on the Research Topic <article-title>Methods in T cell biology: 2022</article-title>
</related-article>
<kwd-group>
<kwd>T cell</kwd>
<kwd>TCR (T cell receptor)</kwd>
<kwd>T cell epitope</kwd>
<kwd>method</kwd>
<kwd>binding prediction</kwd>
<kwd>machine learning</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="6"/>
<page-count count="2"/>
<word-count count="918"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>T Cell Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>T cells are crucial players of immune responses by their ability to specifically recognize foreign, potentially harmful, antigens. To perform such specific recognition, T cells express at their plasma membrane an antigen receptor called the T cell receptor (TCR) (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). The TCR expressed at the plasma membrane in the majority of T cells is composed by a TCR-&#x3b1; and TCR-&#x3b2; heterodimer, which is able to recognize a complex formed by an antigenic peptide coupled to an MHC molecule (pMHC complex). After specific recognition by a pMHC complex the TCR triggers multiple intracellular signals leading to proliferation, target cell killing, cytokine secretion, and differentiation into effector T cells. Although our understanding of the molecular mechanisms governing activation of T cells has dramatically grown in recent years, there is still much to learn.</p>
<p>This Research Topic contains 5 articles covering different aspects in the field of experimental techniques and methods used to investigate fundamental questions in T Cell Biology. Indeed, new technologies have recently appeared that have not only given us a much better understanding of these cells, but have also allowed researchers to genetically modify T cells for the treatment of malignant tumors. The study of TCRs is of crucial importance for fine-tuning immunotherapy of cancer and human infectious diseases. One of the articles in the present topic addresses a review and comparison of different deep learning methods to investigate TCR-peptide/-pMHC binding prediction, as a means to generate tools for the treatment of tumors or infectious diseases (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1014256">Grazioli et&#xa0;al.</ext-link>). In their work, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1014256">Grazioli et&#xa0;al.</ext-link> have tested the reliable performance of state-of-the-art deep learning methods in predicting TCR/pMHC peptide binding for &#x201c;unseen&#x201d; peptides, i.e., sequences that were not present in the training set. For this purpose, they have integrated TCR-peptide/pMHC samples from different databases into a single database (which they have named TChard), and with it they have performed experiments with two state-of-the-art deep learning models for TCR-peptide/pMHC interaction prediction. Their results show that those deep learning methods fail to generalize to unseen peptides, unveiling the need of more robust TCR-peptide/-pMHC interaction prediction, machine learning models. Also of interest is the work presented by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1021067">Hong et&#xa0;al.</ext-link> in which a TCR cloning system not needing single cell technology is described. In their work they use human cytomegalovirus (CMV)-derived peptides, as it is one of the causes of acute graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation, and adoptive transfer of CMV-specific T cells has been shown to restore immune functions against CMV infection (<xref ref-type="bibr" rid="B4">4</xref>). They had previously shown that specific HLA class I allotypes are preferentially used in immune responses to pp65 mediated by CD8 + T cells (<xref ref-type="bibr" rid="B5">5</xref>). Here the authors establish a rapid method for the identification of functional TCRs from CMV pp65 antigen-specific T cells restricted by particular HLA allotypes, and a reverse TCR cloning method for amplifying only specific TCRs from the bulk TCR cDNA pool.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1107366">Schollhorn et&#xa0;al.</ext-link> describe a method to identify by flow cytometry activated T cells, with great sensitivity. They assess activation of CD4+ and CD8+ T cells using a combination of &#x3b2;2-integrins, CD137 and CD154. The interest of this method lies in the fact that the analysis of the expression of &#x3b2;-2 integrins correlates well with cytokine production and preserves cell viability. This approach not only allows detection and quantification of activated T cells in a shorter time than other activation markers (e.g. CD25 or OX40), but also has a lower background staining than CD69. The authors show in their report the potential utility of their method by assessing specific T cell responses to the SARS-CoV-2 spike protein in individuals following vaccination with COVID-19.</p>
<p>With regard to T cell activation, it is well established that three-dimensional organization of the genome, i.e., the organization of chromatin compaction, is intimately associated with lymphocyte development and activation (<xref ref-type="bibr" rid="B6">6</xref>). Dynamic allelic interactions and nuclear locations seem to be especially relevant for the regulation of immune responses. In this context, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1156077">Salataj et&#xa0;al.</ext-link> have published in this Research Topic a detailed protocol to simultaneously detect nascent RNA transcripts (3D RNA FISH), their genomic loci (3D DNA FISH) and/or their chromosome territories (CT paint DNA FISH), in combination with the antibody-based detection of several nuclear factors. In their article, the authors describe the application and efficacy of this protocol in various subtypes of T cells, B cells, macrophages and other cell types. It is of interest to note that this is a very detailed protocol, with a section in which the authors propose several optimizations for potential problems that may arise in the implementation of the method.</p>
<p>On the other hand, after specific TCR stimulation, T lymphocytes are metabolically activated, and the mitochondrial network is of special relevance for proper immune responses. In the last article in this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1197289">G&#xf3;mez-Mor&#xf3;n et&#xa0;al.</ext-link> describe the function of EB1 (a protein that regulates tubulin polymerization and previously identified as a regulator of intracellular transport of CD3-enriched vesicles) in Jurkat and primary T cells. In their work the authors show that the decrease in EB1 expression produces deficient intracellular organization and metabolic strength after T cell activation T cells, suggesting a link between the cytoskeleton and metabolism in response to TCR stimulation, which leads to increased AICD.</p>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>EA: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. MC: Writing &#x2013; review &amp; editing</p>
</sec>
</body>
<back>
<sec id="s2" sec-type="funding-information">
<title>Funding</title>
<p>EA is funded by Consejer&#xed;a de Transformaci&#xf3;n Econ&#xf3;mica, Industria, Conocimiento y Universidades, Junta de Andaluc&#xed;a, Spain (grant PY20_01297), and Agencia Estatal de Investigaci&#xf3;n, Ministerio de Ciencia e Innovaci&#xf3;n, Spain (grant PID2020-113943RB-I00). MC is funded by the Australian National Health &amp; Medical Research Council (NHMRC), Cancer Australia, TDM Foundation and Hearts &amp; Minds Investments.</p>
</sec>
<sec id="s3" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s4" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguado</surname> <given-names>E</given-names>
</name>
<name>
<surname>Martinez-Florensa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aparicio</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Activation of T lymphocytes and the role of the adapter lat</article-title>. <source>Transpl Immunol</source> (<year>2006</year>) <volume>17</volume>(<issue>1</issue>):<page-range>23&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.trim.2006.09.013</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malissen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bongrand</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Early T cell activation: integrating biochemical, structural, and biophysical cues</article-title>. <source>Annu Rev Immunol</source> (<year>2015</year>) <volume>33</volume>:<page-range>539&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112158</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandler</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Call</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Call</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>T cell activation machinery: form and function in natural and engineered immune receptors</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>(<issue>19</issue>):<fpage>7424</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21197424</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riddell</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Goodrich</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Li</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Agha</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Greenberg</surname> <given-names>PD</given-names>
</name>
</person-group>. <article-title>Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones</article-title>. <source>Science</source> (<year>1992</year>) <volume>257</volume>(<issue>5067</issue>):<page-range>238&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1352912</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyun</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>DH</given-names>
</name>
<etal/>
</person-group>. <article-title>Comprehensive analysis of cytomegalovirus pp65 antigen-specific cd8(+) T cell responses according to human leukocyte antigen class I allotypes and intraindividual dominance</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>1591</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01591</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scourzic</surname> <given-names>L</given-names>
</name>
<name>
<surname>Salataj</surname> <given-names>E</given-names>
</name>
<name>
<surname>Apostolou</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Deciphering the complexity of 3d chromatin organization driving lymphopoiesis and lymphoid Malignancies</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>669881</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.669881</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>